EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS

被引：0

作者：

Baraza Cristina, Gomez ^{[1
]}

Francisco Javier, Manero Ruiz ^{[2
]}

Espasol Angela, Pecondon ^{[2
]}

Mendoza Mercedes, Arenere ^{[3
]}

Orbis Iciar, Casiamares ^{[1
]}

Maria Jose, Rabanaque Hernandez ^{[4
]}

机构：

[1] Hosp Univ Miguel Servet, Dept Pharm, Zaragoza, Spain

[2] Hosp Univ Miguel Servet, Rheumatol Serv, Zaragoza, Spain

[3] Hosp Clin Lozano Blesa, Dept Pharm, Zaragoza, Spain

[4] Univ Zaragoza, Fac Med, Dept Microbiol, Prevent Med & Publ Hlth, Zaragoza, Spain

来源：

ATENCION FARMACEUTICA | 2013年 / 15卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Objective: To evaluate the efficacy and safety of tumor necrosis factor alpha inhibitors in Rheumatoid Arthritis (RA). Method: An observational and retrospective study conducted on patients with RA treated at a hospital between May 2000 and December 2009. We analyzed the influence of demographic and clinical factors in the effectiveness of treatments and made a comparison between them. We determined the durability of the anti-TNF-alpha agents and adverse reactions. Results: The efficacy study showed improvement in the clinical variables. The survival analysis showed no significant differences depending on the used drug or treatment line. The safety analysis revealed risk of infections. Conclusion: Infliximab, etanercept, and adalimumab are effective drugs for RA therapy, improving symptoms control and showing similar effectiveness between them.

引用

页码：150 / 157

页数：8

共 50 条

[41] Perforating folliculitis associated with tumour necrosis factor-α inhibitors administered for rheumatoid arthritis
Gilaberte, Y.
Coscojuela, C.
Vazquez, C.
Rosello, R.
Vera, J.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 368 - 371
[42] Tumor necrosis factor inhibitors for rheumatoid arthritis
Dentener, Mieke A.
Wouters, Emiel F. M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19): : 2047 - 2048
[43] ADHERENCE EVALUATIONS FOR TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR RHEUMATOID ARTHRITIS I
Watanabe, J. H.
Saseen, J. J.
Dilokthomsakul, P.
Campbell, J. D.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A148 - A148
[44] A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C
Chen, Yi-Ming
Chen, Hsin-Hua
Chen, Yi-Hsing
Hsieh, Tsu-Yi
Hsieh, Chia-Wei
Hung, Wei-Ting
Lan, Joung-Liang
Chen, Der-Yuan
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 626 - 627
[45] Inhibitors of tumor necrosis factor for rheumatoid arthritis
Moreland, LW
[J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 : 7 - 15
[46] Tumor necrosis factor inhibitors for rheumatoid arthritis
Scott, D. L.
Kingsley, G. H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 704 - 712
[47] Tumor necrosis factor inhibitors for rheumatoid arthritis
Jones, RE
Moreland, LW
[J]. BULLETIN ON THE RHEUMATIC DISEASES, 1999, 48 (03) : 1 - 4
[48] Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice
Aaltonen, Kalle J.
Ylikyla, Suvi
Joensuu, Jaana Tuulikki
Isomaki, Pia
Pirila, Laura
Kauppi, Markku
Rannio, Tuomas
Eklund, Kari
Blom, Marja
Nordstrom, Dan
[J]. RHEUMATOLOGY, 2017, 56 (05) : 725 - 735
[49] Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis
Del Porto, F.
Lagana, B.
Nofroni, I.
Tinti, F.
Mitterhofer, A. P.
D'Amelio, R.
[J]. RHEUMATOLOGY, 2007, 46 (10) : 1626 - 1627
[50] Tumour necrosis factor alpha antagonists in established rheumatoid arthritis: Effectiveness comparative study
Arenere Mendoza, Mercedes
Manero Ruiz, Francisco Javier
Carrera Lasfuentes, Patricia
Navarro Aznarez, Herminia
Pecondon Espanol, Angela
Rabanaque Hernandez, Maria Jose
[J]. MEDICINA CLINICA, 2010, 134 (15): : 665 - 670

← 1 2 3 4 5 →